During the past decade, Hospital Universitario Infanta Cristina; Servicio de Oncologia conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario Infanta Cristina; Servicio de Oncologia" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Abbott Medical Devices" with 2 trials sponsored, "Castilla-La Mancha Health Service" with 2 trials sponsored, "Spanish Breast Cancer Research Group" with 1 trials sponsored and "Spanish Oncology Genito-Urinary Group" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Infanta Cristina; Servicio de Oncologia" #1 collaborator was "Ipsen" with 1 trials as a collaborator, "Seagen Inc." with 1 trials as a collaborator, "Spanish Diabetes Association" with 1 trials as a collaborator and "Syntax for Science, S.L" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario Infanta Cristina; Servicio de Oncologia" are "Type 1 Diabetes" (2 trials), "Atrial Fibrillation" (1 trials), "Bradycardia" (1 trials), "Breast Cancer" (1 trials) and "Carcinoma, Hepatocellular" (1 trials). Many other conditions were trialed in "Hospital Universitario Infanta Cristina; Servicio de Oncologia" in a lesser frequency.

Most popular intervention types in "Hospital Universitario Infanta Cristina; Servicio de Oncologia" are "Drug" (6 trials), "Device" (4 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (3 trials), "Bevacizumab" (2 trials), "Placebo" (2 trials), "Aveir DR Leadless Pacemaker System" (1 trials) and "Cabozantinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario Infanta Cristina; Servicio de Oncologia" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Universitario Infanta Cristina; Servicio de Oncologia". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hospital Universitario Infanta Cristina; Servicio de Oncologia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario Infanta Cristina; Servicio de Oncologia, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".